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SER virus is a member of the family Paramyxoviridae, genus Rubulavirus, which has been isolated from pigs. It is very
closely related to SV5 virus serologically, in protein profile, and in nucleotide sequence. However, unlike SV5, SER induces
minimal syncytium formation in infected CV-1 or BHK cells. Fluorescence transfer experiments between labeled erythrocytes
and infected MDBK cells revealed that SER also induces hemifusion and pore formation with reduced efficiency. The virion
polypeptide profiles of SER and SV5 are very similar, except that the SER F1 subunit shows an apparent molecular weight
that is about 2 kDa higher than that of SV5. Comparison of the deduced amino acid sequences revealed the SER F (551 aa)
to be longer than SV5 F (529 aa) by 22 residues in the cytoplasmic tail (CT) domain. The HN and M gene sequences of the
viruses were found to be very similar. The SER F showed minimal fusion activity when coexpressed with either SV5 or SER
HN. In contrast, SV5 F was highly fusogenic when coexpressed with either HN protein, indicating that the restricted fusion
capacity of SER virus is a property of its F protein. Truncation in the CT of SER F by 22 residues completely rescued its abilityINTRODUCTION
Receptor binding and membrane fusion are the central
mechanisms used by enveloped viruses to enter cells.
Paramyxoviruses have two different proteins which inter-
act to carry out these functions, a fusion protein (F) and
a hemagglutinin–neuraminidase (HN) or its equivalent.
The F protein is directly responsible for merging lipid
bilayers, whereas HN, in addition to its role in virus
attachment, is a cofactor in the fusion process. Although
some paramyxovirus F proteins can induce cell-to-cell
fusion without their homotypic HN protein (Alkhatib et al.,
1990; Horvath et al., 1992; Karron et al., 1997; Tsurudome
et al., 2001), with most paramyxoviruses coexpression of
F and HN from the same serotype is usually required for
fusion activity (Horvath et al., 1992; Hu et al., 1992; Cat-
taneo and Rose, 1993; Malvoisin and Wild, 1993; Bousse
et al., 1994; Heminway et al., 1994).
The F protein is synthesized as an inactive precursor
(F0) which is posttranslationally cleaved by host pro-
teases into two disulfide-linked subunits, F1 and F2.
Cleavage is essential for the fusion capacity of F and for
virus infectivity (Homma and Ohuchi, 1973; Scheid and
Choppin, 1974; Nagai et al., 1976). It has long been
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322known that the uncleaved and the cleaved forms of F
have different conformations (Hsu et al., 1981; Kohama et
al., 1981), and it is believed that, in its role as a fusion
cofactor, HN triggers the conformational change of F.
According to a widely accepted model that has been
derived from studies on F of paramyxoviruses as well as
on HA of influenza virus (Skehel and Wiley, 2000), the
conformational change results first in the exposure of the
hydrophobic fusion peptide at the amino-terminus of F1
generated by the cleavage which allows its insertion into
the target membrane. Subsequently, F1 is folded into a
hairpin-like structure which leads to the fusion of the
target membrane with the viral envelope. Essential struc-
tural elements in the folding process are two heptad
repeats, adjacent to the fusion peptide (HRA) and to the
transmembrane domain (HRB), that form a six-helix bun-
dle core in the hairpin structure (Joshi et al., 1998; Baker
et al., 1999; Dutch et al., 1999, 2001; Matthews et al.,
2000).
The cytoplasmic domains of some viral fusion proteins
have also been found to play an important role in cell
fusion and syncytium formation. For example, the enve-
lope glycoproteins of several retroviruses, including mu-
rine leukemia virus (MuLV), Mason–Pfizer monkey virus,
and equine infectious anemia virus, in addition to cleav-
age–activation of their extracellular domain, undergo a
second proteolytic cleavage step which removes the
C-terminal segment to produce the mature transmem-to cause syncytium formation, whereas other truncations r
that an elongated CT of a paramyxovirus F protein suppre
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brane protein molecule (Green et al., 1981; Rice et al.,
1990; Sommerfelt et al., 1992). It has been shown that theescued
sses its
cleavage of the C-terminal 16-amino-acid R peptide se-
quence from the Env protein of MuLV is important for
virus infectivity as well as membrane fusion activity
(Ragheb and Anderson, 1994b; Rein et al., 1994; Yang and
Compans, 1996). Studies with human immunodeficiency
virus type 2 and simian immunodeficiency virus envelope
glycoproteins have also shown that C-terminal truncation
mutants show significantly enhanced syncytium forma-
tion (Mulligan et al., 1992; Ritter et al., 1993). On the other
hand, elongation of the cytoplasmic tail of influenza virus
HA has been shown to reduce fusion activity (Ohuchi et
al., 1998). For the F protein, cytoplasmic tail deletions in
simian virus 5 (SV5) (Dutch and Lamb, 2001), Newcastle
disease virus (Sergel and Morrison, 1995), and human
parainfluenza type 3 virus show greatly reduced syncy-
tium formation, but in human parainfluenza type 2 virus
such deletions did not affect fusion (Yao and Compans,
1995).
In the present study, we have analyzed the fusion
capacity of a recently identified paramyxovirus, desig-
nated SER. SER had been isolated from the fetus of a
breeding sow showing porcine reproductive and respi-
ratory syndrome, and in a previous serological study it
was found to be a parainfluenza type 2 virus (Heinen et
al., 1998). We show now by comparative nucleotide se-
quence analysis that SER is very closely related to SV5.
However, SER produces minimal cytopathology in sev-
eral infected cell lines in which SV5 induces extensive
cell fusion. In addition, SER differs from SV5 by an ex-
tended cytoplasmic tail of the F protein. The concept that
this extension accounts for the reduced fusion activity of
SER has been supported by expression studies of the F
protein and truncated F mutants. The results provide new
information on the structural features of the cytoplasmic
domain which are important for the regulation of fusion
activity.
RESULTS
Comparison of SER and SV5 phenotypes
Virus growth was analyzed in MDBK and BHK21-F
cells. Both viruses replicated well in MDBK cells, and
maximal HA titers were reached in the cell culture fluid at
about 48 h p.i. Less virus was released from BHK cells,
but again there were no significant differences between
SER virus and SV5 (Fig. 1). Both viruses agglutinated
chicken and guinea pig erythrocytes. With SV5, hemag-
glutination had to be carried out at 4°C, since the virus
eluted rapidly at room temperature. However, such tem-
perature dependence was not observed with SER virus,
which showed stable hemagglutination patterns also at
room temperature. These observations suggest a differ-
ence in the receptor affinity and/or the neuraminidase
activity of both viruses, although no mutations were
found in the amino acids forming the receptor-binding
and catalytic site of HN (see below).
Striking differences between SER virus and SV5 were
found when their fusion activities were compared (Fig. 2,
Table 1). These differences were most distinct in
BHK21-F cells known to be highly susceptible to SV5-
induced fusion (Holmes and Choppin, 1966). At 24 h after
infection with SV5, these cells already showed large
syncytia, and maximal levels of fusion were reached at
72 h p.i. In contrast, syncytia developed much more
slowly and remained smaller when BHK21-F cells were
infected with SER virus. The higher fusion activity of SV5
could also be seen after infection of MDBK cells, but the
differences between both viruses were not so distinct
because of the relatively high resistance of these cells to
syncytia formation. We have also carried out fluores-
cence transfer assays by adding guinea pig erythrocytes
labeled with rhodamine R18 and calcein to SER- and
SV5-infected MDBK cells. SV5 induced lipid mixing (not
shown) and content mixing (Fig. 3) about twice as effi-
ciently as did SER. These results show that SV5 is a
better mediator not only of syncytia formation, but also of
pore formation and hemifusion.
We also compared the polypeptide profiles of purified
virions obtained from MDBK cells. As indicated by the
polyacrylamide gels shown in Fig. 4, the L, HN, NP, P, and
M bands had the same migration rates and relative
intensities with the SV5 and SER virus. Furthermore, with
both viruses the F protein was present in the cleaved
form. However, whereas the small cleavage fragment F2
had the same size with both viruses, the large cleavage
fragment F1 of SER virus showed a lower mobility than
SV5-F1 by about 2 kDa.
FIG. 1. Growth curves of SV5 and SER virus. Confluent monolayers of
MDBK and BHK21-F cells were infected at an m.o.i. of 10 PFU per cell.
HA titres were determined in the culture medium at the times indicated.
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Sequence alignment of HN, F, and M of SV5 and SER
virus
The data described so far suggest that SER virus
differs from SV5 in functions exerted by the viral surface
proteins. We have therefore carried out a comparative
sequence analysis of glycoproteins HN and F. Since the
M protein is thought to directly interact with the cytoplas-
mic tails of both glycoproteins, it was also included in
these studies (Fig. 5).
Comparison of the nucleotide sequences of the F
genes of SER virus (EMBL nucleotide sequence data
base, Accession No. AJ278916) and the W3 strain of SV5
(Paterson et al., 1984) reveals 22 nucleotide exchanges
resulting in 9 amino acid exchanges. All of the amino
acid exchanges are located in the F1 subunit: 6 in the
ectodomain, 1 in the transmembrane domain, and 2 in
the cytoplasmic tail. Neither glycosylation sites nor cys-
teine residues are affected by these mutations. The fu-
sion peptide and furin cleavage site are not involved
either, but one of the mutations in the ectodomain, the
FIG. 2. Formation of syncytia in MDBK and BHK21-F cells infected with SV5 and SER virus. Confluent monolayers of MDBK and BHK21-F cells were
infected at an m.o.i. of 10 PFU per cell. After 40 h incubation at 37° cells were fixed, stained with hematoxylin–eosin, and examined by microscopy.
TABLE 1
Time Course of Syncytium Formation in MDCK and BHK21-F Cells
Infected with SV5 and SER Virus
Cell fusion
h p.i.
MDBK BHK
SV5 SER SV5 SER
24    
48    
72    
Note. Cells were infected and analyzed for syncytia formation as
described in the legend to Fig. 2. , 10 nuclei per syncytium; ,
100 nuclei per syncytium.
FIG. 3. Pore formation in MDBK cells infected with SV5 and SER
virus. Confluent monolayers of MDBK cells were infected at an m.o.i. of
10 PFU per cell. After incubation at 37° for the times indicated, the
medium was removed and a suspension of calcein-labeled guinea pig
erythrocytes (1% in PBS) was added. After 30 min at 4°C, nonadsorbed
erythrocytes were removed and the monolayers were incubated for
another 30 min at 37°. Calcein-labeled MDBK cells were then counted
by fluorescence microscopy.
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exchange of alanine for threonine at position 149, is
located in heptad repeat A, which is an important struc-
tural element in the fusion-competent form of the F pro-
tein. The most interesting nucleotide exchange is lo-
cated at position 1588. It replaces the stop codon of the
F gene of SV5 by a triplet coding for serine. As a result,
there is an extension of the open reading frame into the
extragenic region and an elongation of the cytoplasmic
tail of the F protein of SER virus by 22 amino acids,
explaining the increase in molecular weight seen on
polyacrylamide gels.
When compared to the nucleotide sequence of the
HN gene of the W3 strain of SV5 (Hiebert et al., 1985),
23 nucleotide exchanges are found in the respective
SER sequence (EMBL nucleotide sequence data base,
Accession No. AJ278915), resulting in 16 amino acid
exchanges. One of these is located in the amino-
terminal cytoplasmic tail, and the rest are spread over
the ectodomain of HN. Cysteine residues and glyco-
sylation sites are not involved in these mutations, nor
are affected HN sequences that are highly conserved
in the paramyxovirinae subfamily. In particular and
quite importantly, no exchanges were observed of
amino acids forming the catalytic site believed to be
identical with the receptor binding site of HN (Crennell
et al., 2000).
Analysis of the M gene revealed 10 nucleotide and 6
amino acid exchanges (Sheshberadaran and Lamb,
1990) (EMBL nucleotide sequence data base, Accession
No. AJ278914). One of the mutations resulted in the loss
FIG. 4. Polypeptide profiles of SV5 and SER virus. Viruses were
grown in MDBK cells in the presence of [35S]methionine, cysteine, and
[3H]glucosamine. After purification, virions were analyzed by electro-
phoresis on 10 and 12% SDS–polyamide gels.
FIG. 5. Schematic comparison of SV5 and SER viral envelope glycoproteins and matrix proteins. The differences in the sequences of the proteins
are indicated.
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of a negative charge in SER M, whereas all other amino
acid mutations were conservative.
Expression and analysis of fusion activity of SER F
and HN envelope proteins
Paramyxoviruses enter target cells by the combination
of the functions of the two envelope glycoproteins (F and
HN), and the coexpression of these proteins also results
in characteristic syncytium formation. To better under-
stand the molecular basis of the nonfusogenic pheno-
type of SER virus, the cDNA copies of SER F and HN
mRNAs were amplified by RT–PCR using primers based
on SV5 F and HN gene sequences, respectively, and
were cloned into the pGEM-3 vector as detailed under
Materials and Methods. To investigate the fusion activity
of the SER F and HN proteins, they were expressed in
HeLa-T4 cells using the vaccinia virus–bacteriophage T7
RNA polymerase transient expression system (Fuerst et
al., 1986). As shown in Fig. 6, when the SER F protein was
coexpressed with the SER HN protein, no syncytium
formation was observed. In comparison, SV5 F, when
coexpressed with SV5 F HN, mediates extensive cell
fusion (Horvath et al., 1992). Furthermore, we observed
that coexpression of SER HN with SV5 F induced a high
level of syncytium formation. However, coexpression of
SER F and SV5 HN protein failed to induce cell fusion.
These results indicate that the inability of SER virus to
induce syncytium formation is due to the inability of the
SER F protein to mediate the fusion process.
Generation of F proteins with distinct fusogenic
properties by truncation of the cytoplasmic tail
As shown in Fig. 5, alignment of the deduced amino
acid sequences of the HN and F genes of SER virus with
those of SV5 revealed 16 amino acid exchanges between
the HN proteins of SER and SV5 and 9 amino acid
exchanges between the F proteins of SER and SV5. Of
particular interest was the finding that the SER F protein
had a cytoplasmic domain that was longer than that of
the SV5 F protein by 22 residues. As pointed out above,
studies with human immunodeficiency virus type 2 and
simian immunodeficiency virus envelope (Env) glycopro-
teins have shown that cytoplasmic domain truncation
mutants exhibit significantly enhanced syncytium forma-
tion (Mulligan et al., 1992; Ritter et al., 1993). In addition,
studies with murine leukemia virus have demonstrated
that naturally occurring late cleavage of a small carboxy-
terminal sequence, designated as the R peptide or p2E,
in the cytoplasmic tail results in considerably enhanced
cell-to-cell fusion activity (Ragheb and Anderson, 1994b;
Rein et al., 1994). Therefore, we wished to determine
whether the extended cytoplasmic tail of the SER F
protein is responsible for the nonfusogenic phenotype of
the SER virus F protein. We constructed a series of
cytoplasmic domain truncation mutants by introducing
translational stop codons into the coding sequence for
the cytoplasmic tail of the SER F protein, as indicated in
Fig. 7. Six F cytoplasmic tail truncation mutants were
FIG. 6. Comparison of SV5 and SER glycoprotein-induced giant cell
formation. HeLa-T4 cells were infected with vTF7-3 at a multiplicity of
infection of 10 for 1 h at 37°C and then transfected with plasmids
containing genes encoding SV5 and SER F and HN proteins as indi-
cated. At 20 h posttransfection, cells were observed under the light
microscope for syncytium formation.
FIG. 7. Construction of mutant SER F proteins. Schematic representation of the cytoplasmic tail truncations of SER F are shown. FP denotes the
fusion peptide and TM denotes the transmembrane sequence.
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constructed as described under Materials and Methods
and were designated T9, T17, T22, T29, T34, and T41. The
T41 mutant has the entire cytoplasmic tail deleted. The
T22 mutant has a deletion of 22 amino acids, resulting in
a truncated cytoplasmic domain with the same length as
that of the SV5 F protein.
Since cytoplasmic domain truncation could affect the
transport to the cell surface, we measured the levels of
protein expressed intracellularly and on the cell surface
for wild-type (wt) SER F and truncated F mutants using
the vaccinia virus–T7 RNA polymerase expression sys-
tem. Pulse-chase labeling was used to examine the
cleavage of these proteins. The levels of cell surface
expression of the transiently expressed proteins were
measured by cell surface biotinylation analysis. As
shown in Fig. 8, both the wild-type SER F0 and SV5 F0
precursors were cleaved and detected in lysates during
a 2-h chase. The T9, T17, T22, and T29 mutant proteins
have a significant fraction of F1 in a 2-h chase. In con-
trast, the T34 and T41 mutants were found not to be
efficiently cleaved at the 2-h chase period.
To compare the cell surface expression levels of the
wild-type and mutant SER F proteins relative to that of the
SV5 F protein, the proteins were expressed transiently in
HeLa-T4 cells and were analyzed by a biotinylation assay
at the 2-h chase time. We observed that only the cleaved
F1 form of the wild-type or most of the truncated SER F
proteins was detected on the cell surface and that the
levels were similar to that of the SV5 F protein. However,
the T34 and T41 mutants that failed to be cleaved were
not detected on the cell surface at the 2-h chase time.
These data indicate that these mutants exhibit defects in
transport to the cell surface and/or defects in protein
processing.
The extent of syncytia formed by coexpression of the
SV5 F/SV5 HN, SER F/SV5 HN, SER HN, and mutant F
proteins at 16–20 h after transfection was observed by
phase-contrast microscopy and is shown in Fig. 9. The
quantitative measurement of the cell fusion activity of wt
SV5 F, wt SER F, or each SER F mutant with coexpression
of SER HN is indicated in Table 2. The removal of only 9
amino acids from the C-terminus of the envelope protein
had little effect on the enhancing of fusion activity. How-
ever, significant fusion of HeLa-T4 cells was observed
when 17 amino acids were removed, and when 22 amino
FIG. 8. Expression of SV5 and SER virus envelope glycoproteins.
HeLa-T4 cells were infected with vTF7-3 at a multiplicity of infection of
10 for 1 h at 37°C and then transfected with plasmids containing genes
encoding wt SV5 F, wt SV5 HN, wt SER HN, and the wild-type or
truncation mutant of SER F protein as indicated. At 16 h posttransfec-
tion, cells were labeled with 100 Ci of [35S]methionine and [35S]
cysteine. After the labeling, cells were biotinylated and immunoprecipi-
tated with rabbit anti-SV5 antiserum plus protein A–agarose beads at
4°C overnight. The samples were prepared with reducing sample
buffer and analyzed by SDS–10% PAGE.(A) Cell lysate. (B) Cell surface.
FIG. 9. Fusion activity of wild-type and mutant SER F protein. HeLa-T4 cells were infected with vTF7-3 at a multiplicity of infection of 10 for 1 h at
37°C and then cotransfected with plasmids containing genes encoding wild-type SV5 F/SV5 HN, SER F/SV5 HN, or truncation mutants of SER F and
wt SER HN protein. At 20 h posttransfection, cells were observed under the light microscope for syncytium formation. (A) SV5 F- and HN-transfected
cells. (B) SER F- and SV5 HN-transfected cells. (C–H) T9, T17, T22, T29, T34, or T41 and SER HN-transfected cells.
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acids were truncated the level of syncytia further in-
creased to an extent similar to that produced by the
wild-type SV5 F protein. This deletion generates an F
protein with a cytoplasmic tail of the same length as the
SV5 F protein. The F mutant with a deletion of 29 amino
acids showed only a slightly reduced level of syncytial
formation compared to that observed in SV5 F-trans-
fected cells. However, further shortening of the cytoplas-
mic tail toward the TM domain, resulting in a deletion of
34 or more amino acids, resulted in a complete loss of
fusogenic activity. As described above, the latter mutant
proteins were also not transported efficiently to cell sur-
faces, which probably accounts for their lack of fusion
activity.
Oligomerization of wild-type and mutant SER F
proteins
Studies with human immunodeficiency virus type 2
and simian immunodeficiency virus Env glycoproteins
have shown that cytoplasmic domain truncation mutants
alter the conformation of the external domain of mem-
brane proteins (Mulligan et al., 1992; Spies et al., 1994).
Also, F protein C-terminal mutants in human parainflu-
enza type 3 virus showed a defect in oligomerization (Yao
and Compans, 1995). To further understand the effects of
the cytoplasmic tail length of SER F protein, we com-
pared the patterns of oligomer formation of the wild-type
and truncated SER F as well as SV5 F proteins after
cross-linking with the reagent 3,3-dithiobis[sulfosuccin-
imidyl propionate] (DTSSP). As shown in Fig. 10, we
observed that the wild-type and truncated SER F proteins
are resolved as three prominent bands migrating at the
positions of homotrimers, homodimers, and monomers,
as reported for the SV5 F protein (Russell et al., 1994).
Although the relative ratio of homotrimers to monomers
for SER F appeared to be lower, with the T34 and T41
mutants, which have the two most extensively truncated
cytoplasmic tails, the relative ratio of homotrimers to
monomers was much lower than that of the SV5 F pro-
tein, or other SER F mutants as well as the wild-type SER
F protein, indicating less efficient oligomerization. The
other mutant F proteins showed ratios of homotrimers to
monomers which were similar to that of the wild-type
SV5 F protein. These data indicate that oligomerization of
the SER F protein is not greatly affected by changes in its
cytoplasmic tail length, except for the most extensive
truncations, which show less efficient oligomerization.
DISCUSSION
We show here that the reduced ability to induce cell
fusion is the most prominent phenotypic difference of
SER virus compared to the W3 strain of SV5. To deter-
mine the structural basis for this functional difference we
first analyzed the viral polypeptides by polyacrylamide
gel electrophoresis, which revealed an increased molec-
ular weight of the SER F1. Nucleotide sequence analysis
showed that this increase was due to an extension of the
cytoplasmic tail by 22 amino acids. Except for one amino
acid exchange in heptad repeat A, none of the other
mutations observed in the F protein were located in
domains known to be critical for fusion activity, i.e., the
fusion peptide, cleavage activation site, and heptad re-
peat B. Likewise, no amino acid exchanges with obvious
structural or functional relevance were found in the HN
TABLE 2
Syncytium-Forming Activity of SV5 F, SER F, and Mutant SER F Proteins
SV5 F SER F T-7 T-17 T-22 T-29 T-34 T-41
Syncytia (percentage of cells)a 35–40% 0 1–2% 30% 35–40% 30% 0 0
a HeLa-T4 cells were infected with vTF7-3 at an m.o.i. of 10 at 37°C for 1 h and then were transfected with SV5 F and HN, SER F and SV5 HN, or
SER HN and truncation mutants of SER F protein. At 20 h posttransfection, syncytium formation was examined in four different fields under the light
microscope. The values shown are the percentages of nuclei found in syncytia.
FIG. 10. Cross-linking of wild-type SV5 F, SER F, and mutant SER F
proteins. Cells were transfected with SV5 F, SER F, and mutant SER F
genes as shown. At 16 h posttransfection, cells were labeled with 100
Ci of [35S] methionine and [35S] cysteine for 2 h and incubated in
chase medium for 2 h. The labeled cells were detached by 5 mM EDTA
in PBS deficient in Mg2 and Ca2 (PBS-), washed, and resuspended in
100 l of PBS- buffer. The cells then were solubilized in 0.5% NP-40,
incubated with 2 mM DTSSP at 4°C for 60 min, and quenched with 50
mM glycine for 5 min at 4°C. Immunoprecipitation was performed after
the cross-linking reactions, and proteins were analyzed by SDS–3.5%
PAGE under nonreducing conditions. The positions of the monomer,
dimer, and trimer are indicated as 1, 2, and 3, respectively.
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protein. In particular, amino acids known to form the
combined catalytic and receptor binding site of HN were
not altered. Most of the amino acid exchanges in the M
protein were conservative and therefore unlikely to alter
the interaction between M and the cytoplasmic tails of
the viral glycoproteins. When HN and F of both viruses
were expressed in different combinations from vectors, it
became even clearer that neither M nor any of the other
viral proteins were responsible for the reduced fusion
capacity of SER virus, but that this was specifically due to
the F protein of this virus. Finally, expression studies
employing truncation mutants definitively showed that
the reduced fusion capacity of SER was the conse-
quence of the extension of the cytoplasmic tail of F. The
results obtained with the truncation mutants indicated
also that syncytia formation required a cytoplasmic tail
with a length ranging between 13 (mutant T29) and 25
(mutant T17) amino acids. Optimal fusion was obtained
when the tail contained 20 amino acids (mutant T22),
which is exactly the length of the tail of the F protein of
the W3 strain of SV5. Short (mutant T9) and extensive
(mutants T34 and T41) truncations of F were not compat-
ible with fusion. As indicated by reduced posttransla-
tional proteolytic cleavage and reduced surface expo-
sure, the mutants with extensive truncations did not
induce fusion because of impaired transport which, as
shown by cross-linking studies, was the result of incom-
plete trimerization. These observations support the con-
cept that the cytoplasmic tails can promote oligomeriza-
tion of transmembrane proteins (Takimoto et al., 1992;
Yao and Compans, 1995; Paterson et al., 2000). In con-
trast, trimerization, proteolytic cleavage, and exposure at
the cell surface were not or were only slightly reduced
when the cytoplasmic tail of SER F retained its full length
of 42 amino acids or contained only a small truncation of
8 amino acids. Thus, it appears that the cytoplasmic tail
has a direct regulatory function in the fusion process
which is different from its role in oligomerization and
surface transport.
SER virus is apparently able to infect cells via virus–
cell fusion, and after release it spreads to other cells but
fails to spread efficiently to neighboring cells via cell-to-
cell fusion. The observation that the F protein of SER has
a reduced efficiency to induce syncytia as well as fusion
between MDBK cells and erythrocytes suggests that
there are differences in virus-to-cell fusion and in cell-
to-cell fusion. It is also conceivable that the differential
fusion properties of SER and SV5 reflect differences in
the entry mechanisms of both viruses. Several possible
mechanisms may be envisioned for the defect in SER
fusion activity. First, the C-tail of the SER fusion protein
may be directly involved in regulating the fusion function
of the F protein. The Env protein of MuLV undergoes a
proteolytic cleavage during virus assembly that removes
its C-terminal 16-amino-acid segment, designated as the
R peptide, which has been shown to be important in
regulating the fusion activity of the Env protein and acti-
vating virus infectivity (Ragheb and Anderson, 1994a;
Rein et al., 1994; Yang and Compans, 1996; Januszeski et
al., 1997; Li et al., 2001). The truncation of the SER F
protein C-tail by 17 or 22 amino acids may activate the
cell fusion activity of the SER F protein in much the same
way that cleavage of the R peptide activates the Env
protein of MuLV. Thus it appears that a fusion-suppres-
sive domain is present within the cytoplasmic C-terminal
17 amino acids. It will be of interest to investigate the
essential features of this fusion-suppressive domain by
mutagenesis. The SER F C-tail may restrict fusion be-
cause of its size or by affecting interaction between
monomers or between the C-tail and other cellular fac-
tors, thus limiting movement in the lipid membrane which
may be necessary for cell-to-cell fusion. It has been
reported that elongation of the cytoplasmic tail of the
influenza virus HA protein by as little as 1 amino acid
reduced fusion activity significantly, whereas the addition
of 5 amino acids abolished fusion activity completely
(Ohuchi et al., 1998). On the other hand, the length of the
cytoplasmic tail of the SER F protein is comparable to
that of SV-41 F, which is the longest among the
paramyxovirus F proteins (Tsurudome et al., 1991). Since
the SV-41 F protein is able to induce cell fusion, the
specific amino acids sequence of the SER F C-tail rather
than the length appears to be a more important factor in
the regulation of membrane fusion activity. A recently
reported canine isolate of SV5, called strain T1, has 7
amino acid exchanges in comparison to the amino acid
sequence of the SER F protein and also has a cytoplas-
mic tail 22 amino acids longer than that of the W3 strain
of SV5. Interestingly, truncation of the C-terminal 22
amino acids of the T1 strain only resulted in weak fusion
activity (Ito et al., 2000), whereas truncation of the C-
terminal 22 amino acids of the SER F protein resulted in
a highly fusogenic protein like the SV5 F protein. These
results indicate that fusion activity can also be regulated
by differences in other domains of the F protein.
Our data show that SER and SV5 are closely related
variants. Comparison with the W3 strain has revealed
98.6% nucleotide sequence homology in the SER HN, F,
and M genes, except for the extension at the cytoplasmic
tail of F. Almost complete sequence identity was also
observed when the SER and SV5 P/V genes were com-
pared (R. E. Randall, personal communication). SV5 was
originally isolated from rhesus and cynomolgus monkey
kidney cell cultures (Hull et al., 1956) and was later also
found in man and dogs (Randall et al., 1987). SER is
therefore the first porcine SV5-related virus. SER is
clearly different from La Piedad Michoacan virus, an-
other porcine rubulavirus, causing the so-called blue-eye
disease endemic in Mexico (Moreno-Lopez et al., 1986).
Although SER virus was isolated from an animal with
porcine reproductive and respiratory syndrome, it is not
known whether it plays a pathogenic role in this disease.
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It also remains to be seen whether the extended cyto-
plasmic tail of F or any of the other mutations observed
in SER virus are responsible for an alteration in host
range.
It is relevant that the SV5 F gene possesses an open
reading frame after the stop codon that follows the codon
for the C-terminal residue at amino acid 529, and this
reading frame codes for a sequence which corresponds
precisely to that of the remaining 22 amino acids of the
SER F protein. This strongly supports the idea that SV5 F
arose as a truncated variant of a progenitor virus with an
elongated F protein resembling that of SER virus. This
truncation is likely to have resulted in increased cell
fusion activity. Since SV5 was identified based on its
cytopathic effect of causing cell fusion in monkey kidney
cells (Hull et al., 1956), it may represent a cytopathic
variant of a noncytopathic virus with an elongated cyto-
plasmic domain.
MATERIALS AND METHODS
Cells and viruses
HeLa-T4, MDBK, MDCK, and CV-1 cells were obtained
from the American Type Culture Collection (Rockville,
MD). BHK21-F cells were originally obtained from the
Virology Laboratory of Rockefeller University (New York).
Cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal calf se-
rum (GIBCO BRL, Gaithersburg, MD). The W3 strain of
SV5 was used. SER virus was obtained from Dr. E.
Heinen and Dr. N. Schmeer (Bayer AG, Leverkusen, Ger-
many). The vTF7-3 recombinant vaccinia virus (WR
strain) (Fuerst et al., 1987) expressing the T7 polymerase
and the wild-type vaccinia virus (IHD-J strain) were pro-
vided by Dr. Bernard Moss (National Institutes of Health,
Bethesda, MD). The vaccinia viruses were grown on
HeLa-T4 cells, and the titers of the viruses were deter-
mined by plaque assay on CV-1 cells. SV5 and SER virus
were propagated in MDBK and MDCK cells. The virus
titers were determined by the hemagglutination method
using chicken or guinea pig erythrocytes.
Cloning and sequencing of the F, HN, and M genes of
SER
Full-length cDNA clones for the F, HN, and M genes of
SER were amplified based on the sequence data of the
SV5 genes. The vRNA was prepared from SER virus-
infected MDCK cells and from purified virus using an
RNA-Easy Kit, and the cDNA was synthesized by using a
One-Step RT–PCR kit (Qiagen, Valencia, CA). The se-
quences coding for F, HN, and M were determined using
automated DNA sequencers of the Emory DNA Sequenc-
ing Facility and of the Institute of Virology, Marburg (Ger-
many). F and HN were expressed from pGEM3 vector
under the control of the T7 promoter.
Construction of truncated SER F mutants
The cytoplasmic tail-truncated SER F genes were con-
structed by introducing premature stop codons at posi-
tions of the codons for aa 511, aa 518, aa 523, aa 530, aa
535, and aa 543 of the SER F protein. The primer-directed
mutagenesis PCR was performed by using a Stratagene
Quick Change Site-Directed Mutagenesis Kit (Strat-
agene, La Jolla, California) according to the manufactur-
er’s instructions. The pGEM3-SER F plasmid was used
as template and the primer pairs which have stop
codons at desired positions were synthesized. All the
cloned constructs were sequenced to confirm the pres-
ence of the desired mutations and the absence of addi-
tional mutations.
Protein expression, radioactive labeling, and
immunoprecipitation
To analyze the proteins present in SV5 and SER viri-
ons, virus was grown in monolayers of MDBK cells in the
presence of 35S-Promix (5 Ci/ml) or [3H]glucosamine (5
Ci/ml) (Amersham–Buchler, Braunschweig, Germany)
and purified from the supernatant by ultracentrifugation
on 10–40% potassium tartrate density gradients. The
wild-type and mutant SER proteins were expressed by
using the recombinant vaccinia virus T7 transient ex-
pression system (Fuerst et al., 1987). HeLa-T4 cells were
seeded in 35-mm dishes to 70–80% confluence and were
infected with vTF7-3, which expresses T7 polymerase, at
a multiplicity of infection of 10 for 1 h. Lipofectin (GIBCO
BRL) was used to transfect the vTF7-3-infected HeLa-T4
cells with 3 g of plasmid DNA containing the wild-type
or mutant SER F protein coding sequences. At 16–20 h
post transfection, the cells were starved in Eagle’s me-
dium deficient in methionine and cysteine for 45 min,
labeled with 100 Ci of [35S]Met-Cys (DuPont NEN, Wil-
mington, DE) in 600 l of Eagle’s deficient medium for
1 h, and then chased in DMEM medium with 10% fetal
calf serum for 2 h. Cells were lysed in lysis buffer (150
mM NaCl, 50 mM Tris–HCl, 1 mM EDTA, 1% Triton X-100,
1% sodium deoxycholate, pH 7.5), and the SER F proteins
were immunoprecipitated with rabbit anti-SV5 antibody
and protein A–agarose beads (Pierce Chemical Co.,
Rockford, IL) at 4°C for at least 5 h. Proteins were
characterized by sodium dodecyl sulfate–polyacrylamide
gel electrophoresis (SDS–PAGE) and by subsequent au-
toradiography.
Syncytium formation assays
To analyze cell fusion induced by SV5 and SER virus,
confluent monolayers were infected at an m.o.i. of about
10 PFU/cell and monitored for the development of syn-
cytia from 10 to 72 h p.i. Although previous studies of
SV5-induced fusion have employed CV-1 or BHK cells,
we observed that HeLa-T4 cells were also very suscep-
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tible to fusion, and they were used to analyze fusion
induced by HN and F expressed from vectors. Thirty-five-
millimeter dishes of 80% subconfluent HeLa-T4 cells
were infected for 1 h with vTF7-3 at an m.o.i. of 10 and
then cotransfected with 3 g of truncated mutant or wt
SER F plasmid DNA and 3 g of wt SER HN plasmid DNA
mixed with 10 l of Lipofectin (GIBCO BRL) in 1 ml of
DMEM. After 16–20 h of incubation at 37oC, the formation
of syncytia was compared with cells cotransfected with
wt SV5 F/HN. Syncytial formation was photographed and
the syncytia were counted in four different fields using a
phase-contrast microscope.
Lipid mixing and pore formation assays
Lipid mixing and pore formation were determined es-
sentially as described previously (Fischer et al., 1998),
using guinea pig erythrocytes labeled with octadecylrho-
damine (R18) and calcein, respectively.
Radiolabeling and biotinylation of cell surface
proteins
Cell surface protein expression was detected by a
surface biotinylation assay (LeBivic et al., 1990). At 16 h
posttransfection, HeLa-T4 cells were starved with methi-
onine- and cysteine-deficient Eagle’s medium for 45 min,
pulse-labeled with 100 Ci of [35S]methionine and cys-
teine for 1 h, and chased for 2 h with complete medium
containing 10% fetal calf serum. At the end of labeling,
cells were washed three times with ice-cold PBS–CM
(PBS containing 0.1 mM CaCl2 and 1 mM MgCl2) and
incubated with 0.5 mg of NHS-SS-Biotin (Pierce) in 1 ml
of PBS–CM at 4°C for 30 min. Unreacted biotin was
quenched by adding fresh DMEM. Cells were lysed with
lysis buffer and immunoprecipitated with rabbit anti-SV5
antibodies and then protein A–agarose beads at 4°C for
at least 5 h, respectively. Samples were washed three
times in RIPA buffer and then divided into two equal
aliquots. One aliquot was used for immunoprecipitation
and the other was treated with 10 l of 10% SDS and
heated at 95°C for 5 min. The eluted proteins were then
dissolved in 1 ml of lysis buffer, incubated with 10 l of
streptavidin–agarose (Pierce) for at least 2 h at 4°C, and
characterized by SDS–8% PAGE and by subsequent au-
toradiography.
Chemical cross-linking
Chemical cross-linking of proteins was performed by a
method similar to that described by Russell et al. (1994)
using the cross-linking reagent DTSSP (Pierce). Briefly,
HeLa-T4 cells were transfected and metabolically la-
beled by [35S]methionine and cysteine as described
above. At 16 h posttransfection, the cells were detached
by 5 mM EDTA in PBS deficient in Mg2 and Ca2 (PBS)
buffer, washed, and resuspended in 100 l of PBS
buffer. The cells then were solubilized in 0.5% NP-40,
incubated with 2 mM DTSSP at 4°C for 60 min, and
quenched with 50 mM glycine for 5 min at 4°C. Immu-
noprecipitation was performed after the cross-linking
reactions, and proteins were analyzed by SDS–3.5%
PAGE under nonreducing conditions.
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